29th Annual North American Cystic Fibrosis Conference

W04: INF/MIC: Epidemiology & Management of Infection

Oct 8, 2015 10:00am ‐ Oct 8, 2015 11:45am

Standard: $49.99

Description

Observations in respiratory microbiology are presented, including factors associated with Burkholderia spp. eradication & NTM acquisition. Emphasis on P. aeruginosa (Pa) will include trends in aztreonam susceptibility, response to combined tobramycin & azithromycin & analyses describing stages of infection with mucoid Pa. Ivacaftor's effect on the microbiome in 'Celtic' G551D is presented.

Educational Objectives:

  1. Describe current trends in P. aeruginosa infection in CF & variable response to common therapeutics including antibiotics & CFTR modulators.
  2. Explain environmental risk factors for non-tuberculosis mycobacteria & potentially successful eradication regimens for Burkholderia.
  3. Use observations of the complex respiratory microbiome to improve CF care.

Speaker(s):

You must be logged in and own this session in order to post comments.